3 results match your criteria: "National Clinical Research Center for Kidney Diseases Beijing 100853[Affiliation]"

Pericentrin expression in pancreatic β cells is associated impaired glucose tolerance.

Am J Transl Res

April 2019

Department of Nephrology, Chinese People's Liberation Army General Hospital, Chinese People's Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing 100853, China.

Objective: To explore the role and mechanism of pericentrin (PCNT) in impaired glucose tolerance.

Methods: Mouse model of specific PCNT reduction in β-cells (PCNTβPCNT) was built using a Tet-on induction system; mouse model of impaired glucose tolerance was built by high-fat feeding. MIN6 cells were divided into control and Si-PCNT groups.

View Article and Find Full Text PDF

The role and difference of TLR2 and TLR4 in rhabdomyolysis induced acute kidney injury in mice.

Int J Clin Exp Pathol

February 2018

Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing 100853, China.

To investigate the role of toll like receptors (TLRs) 2 and 4 in rhabdomyolysis (RM)-related acute kidney injury (AKI). Wild-type (WT) mice and TLR2 knockout (TLR2) or TLR4 knockout (TLR4) mice were injected with either saline (sham) or glycerin (to induce RM-related AKI). Samples were collected for detection of 0 h 24 h (Cr) creatinine, urea nitrogen (BUN), creatine kinase (CK), and PAS staining of renal tissues.

View Article and Find Full Text PDF

Long term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis: a meta-analysis.

Int J Clin Exp Med

May 2015

Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing 100853, China.

Background: Low calcium dialysate with 1.25 mmol/l calcium concentration has been proposed to replace standard calcium dialysate in peritoneal dialysis patients taking calcium-containing phosphate binder to prevent hypercalcaemia. We conducted a meta-analysis to evaluate long term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis.

View Article and Find Full Text PDF